TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026)
TherapeuticsMD (TXMD) posted Change in Account Payables of -$340000.0 for Q1 2026, down 398.25% on a QoQ basis from $114000.0 in Q4 2025, and down 314.63% year-over-year from $158409.1 in Q1 2025.
TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026) Analysis & Trends
TherapeuticsMD's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$340000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 314.63% year-over-year to -$340000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$139000.0 (down 475.68% YoY) and the FY2025 annual result came in at $119000.0, down 48.48% from the prior year.
- Change in Account Payables was -$340000.0 for Q1 2026 at TherapeuticsMD, down from $114000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $174000.0 in Q2 2025 and bottomed at -$818000.0 in Q2 2023.
- A 5-year average of -$196235.3 and a median of -$82000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 946.84% — and 2025, when it soared 4250.0%.
- TherapeuticsMD's Change in Account Payables stood at $79000.0 in 2022, then plunged by 946.84% to -$669000.0 in 2023, then soared by 103.59% to $24000.0 in 2024, then jumped by 375.0% to $114000.0 in 2025, then slumped by 398.25% to -$340000.0 in 2026.
- Business Quant data shows TXMD's Change in Account Payables at -$340000.0 in Q1 2026, $114000.0 in Q4 2025, and -$87000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | -340,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -340,000.00 |
| Mar 31, 2026 | -340,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | -669,000.00 |
| Dec 31, 2023 | -669,000.00 |